Trial intelligence / Profile preview

FOLFOX-A in Locally Advanced Pancreatic Cancer

NCT02578732Phase 2Completed

Sponsor
Brown University
Start
Jul 2016
Primary completion
Dec 2019
Modality
DNA Intercalators/Alkylators, Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of paclitaxel, oxaliplatin, folinic acid, fluorouracil in pancreatic ductal adenocarcinoma (PDAC), sponsored by Brown University. Started Jul 2016; status: completed.

02

Drugs

paclitaxeloxaliplatinfolinic acidfluorouracil
03

Conditions

pancreatic ductal adenocarcinoma (PDAC)

Beyond the preview

Go deeper on NCT02578732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02578732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call